Hitting Undruggable Targets: Viewing Stabilized Peptide Development through the Lens of Quantitative Systems Pharmacology
| Autor: | Tejas Navaratna, Lydia Atangcho, Greg M. Thurber |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
chemistry.chemical_classification
0303 health sciences Chemistry Druggability Peptide Computational biology Biochemistry Peptides Cyclic Article 03 medical and health sciences 0302 clinical medicine In vivo Drug Design Animals Humans Peptides Molecular Biology 030217 neurology & neurosurgery 030304 developmental biology Systems pharmacology |
| Zdroj: | Trends in biochemical sciences. 44(3) |
| ISSN: | 0968-0004 |
| Popis: | Stabilized peptide therapeutics have the potential to hit currently undruggable targets, dramatically expanding the druggable genome. However, major obstacles to their development include poor intracellular delivery, rapid degradation, low target affinity, and membrane toxicity. With the emergence of multiple stabilization techniques and screening technologies, the high efficacy of various bioactive peptides has been demonstrated in vitro albeit with limited success in vivo. Here we discuss the chemical and pharmacokinetic barriers to achieving in vivo efficacy, analyze the characteristics of FDA-approved peptide drugs, and propose a developmental tool that considers the molecular properties of stabilized peptides in a comprehensive and quantitative manner in order to achieve the necessary rates for in vivo delivery to the target, efficacy, and ultimately, clinical translation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect